Avalyn Pharma Inc.

AVLN

Figures shown here come from public SEC filings. Dates beside each section show the available history.

Annual Financial Review

Annual financial history is not available for this company.

SEC filings supply these figures; updates after the dates shown are not included. No annual financial history is available for this company. The latest insider filing shown is dated May 5, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Independent insiders buying near the same time

2026-05-01–2026-05-01: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-05-01	Novo Holdings A/S · 10% owner	Voting Common Stock	P — Open market or private purchase	+555,555	18.00	SEC filing
2026-05-01	Carroll Jill · Director	Common Stock	P — Open market or private purchase	+277,778	18.00	SEC filing
2026-05-01	George Simeon · 10% owner	Common Stock	P — Open market or private purchase	+277,777	18.00	SEC filing
2026-05-01	George Simeon · 10% owner	Common Stock	P — Open market or private purchase	+277,778	18.00	SEC filing

Showing 4 of 4 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-05-01	Novo Holdings A/S · 10% owner	Series C-2 Preferred Stock	C — Conversion of derivative security	−5,587,603	SEC filing
2026-05-01	Novo Holdings A/S · 10% owner	Series C-1 Preferred Stock	C — Conversion of derivative security	−25,899,284	SEC filing
2026-05-01	Novo Holdings A/S · 10% owner	Series D Preferred Stock	C — Conversion of derivative security	−12,558,081	SEC filing
2026-05-01	FMR LLC · 10% owner, other	Series B Preferred Stock	C — Conversion of derivative security	−80,291	SEC filing
2026-05-01	Wellington Biomedical Innovation Master Investors (Cayman) II L.P. · 10% owner	Series C-1 Convertible Preferred Stock	C — Conversion of derivative security	−20,482,289	SEC filing
2026-05-01	George Simeon · 10% owner	Series C-1 Convertible Preferred Stock	C — Conversion of derivative security	−27,309,719	SEC filing
2026-05-01	Novo Holdings A/S · 10% owner	Voting Common Stock	C — Conversion of derivative security	+3,327,734	SEC filing
2026-05-01	FMR LLC · 10% owner, other	Common Stock	C — Conversion of derivative security	+225,843	SEC filing

Showing 8 of 19 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.